Lintuzumab-Ac225 in Combination with Cladribine + Cytarabine + Filgastrim + Mitoxantrone (CLAG-M) for Relapsed/Refractory Acute Myeloid Leukemia

NCT03441048 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

BIOLOGICAL: Lintuzumab-Ac-225
DRUG: Cladribine
DRUG: Cytarabine
DRUG: Mitoxantrone
DRUG: G-CSF

Sponsor

Medical College of Wisconsin